Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Maria Czyżewska"'
Autor:
Aneta Bąk, Katarzyna Skonieczka, Anna Jaśkowiec, Anna Junkiert-Czarnecka, Marta Heise, Maria Pilarska-Deltow, Stanisław Potoczek, Maria Czyżewska, Olga Haus
Publikováno v:
Hereditary Cancer in Clinical Practice, Vol 19, Iss 1, Pp 1-11 (2021)
Abstract Background A small but important proportion of patients (4–10 %) with AML have germline mutations. They can cause the development of AML at an earlier age, confer a higher risk of relapse or predispose to secondary leukemias, including the
Externí odkaz:
https://doaj.org/article/47c78243390c4d95a4e75a4a4b5b9c76
Autor:
Joanna Góra-Tybor, Aleksandra Gołos, Damian Mikulski, Grzegorz Helbig, Tomasz Sacha, Krzysztof Lewandowski, Joanna Niesiobędzka-Krężel, Maria Bieniaszewska, Hubert Wysogląd, Olga Grzybowska-Izydorczyk, Ilona Seferyńska, Marta Sobas, Maria Czyżewska, Agnieszka Michalska, Waldemar Sawicki, Malwina Mazur, Marek Hus, Ewa Bodzenta, Magdalena Olszewska-Szopa, Martyna Włodarczyk, Elżbieta Patkowska, Wojciech Świstek, Krzysztof Jamroziak
Publikováno v:
Clinical lymphoma, myelomaleukemia. 23(1)
Ruxolitinib is widely used in myelofibrosis (MF). However, some patients do not optimally respond and require more efficacious treatment. Our analysis aimed to establish predictors of ruxolitinib response.We designed a multicenter, retrospective anal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b94797833b4fefcc3b28a49efc769903
https://pubmed.ncbi.nlm.nih.gov/36396583
https://pubmed.ncbi.nlm.nih.gov/36396583
Searching for germline mutations in the RUNX1 gene among Polish patients with acute myeloid leukemia
Autor:
Anna Jaśkowiec, Stanisław Potoczek, Katarzyna Skonieczka, Anna Junkiert-Czarnecka, Aneta Bąk, Marta Heise, Maria Pilarska-Deltow, Maria Czyżewska, Olga Haus
Publikováno v:
Leukemia & Lymphoma. 62:1749-1755
The aim of the study was the identification of constitutional RUNX1 mutations among AML patients. The study group included 100 patients of Polish origin, diagnosed with de novo AML. 14 out of 100 AML patients had together 17 RUNX1 mutations, three of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b028ac9ebb63f5e8ff151667de9af170
https://doi.org/10.1080/10428194.2021.1881503
https://doi.org/10.1080/10428194.2021.1881503
Autor:
Aneta, Bąk, Katarzyna, Skonieczka, Anna, Jaśkowiec, Anna, Junkiert-Czarnecka, Marta, Heise, Maria, Pilarska-Deltow, Stanisław, Potoczek, Maria, Czyżewska, Olga, Haus
Publikováno v:
Leukemialymphoma. 62(7)
The aim of the study was the identification of constitutional
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1e0b6dfda1e82f22c4c58357d4545afd
https://pubmed.ncbi.nlm.nih.gov/33563056
https://pubmed.ncbi.nlm.nih.gov/33563056
Autor:
Monika Siemieniuk-Rys, Ewa Duszenko, Ewa Wawrzyniak, Marzena Watek, Aleksandra Kotkowska, Katarzyna Skonieczka, Wanda Knopinska-Posluszny, Sebastian Grosicki, Aleksandra Gołos, Jadwiga Hołojda, Justyna Rybka, Jerzy Holowiecki, Agnieszka Pluta, Barbara Pienkowska-Grela, Malgorzata Wach, Lidia Gil, Agnieszka Wierzbowska, Tadeusz Robak, Mariola Iliszko, Anna Jaskowiec, Renata Woroniecka, Anna Jachalska, Malgorzata Jarmuz-Szymczak, Olga Haus, Maria Czyżewska, Anna Ejduk, Barbara Mucha, Marta Szarawarska, Anna Przybylowicz-Chalecka, Agnieszka Kopacz, Agnieszka Klonowska
Publikováno v:
Leukemia & Lymphoma. 58:889-897
Monosomal karyotype (MK) and complex karyotype (CK) are poor prognostic factors in acute myeloid leukemia (AML). A comprehensive analysis of cytogenetic and clinical factors influencing an outcome of AML-CK+ was performed. The impact of cladribine co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adbf3e11f74b3bc095cf830c3dd8cf36
https://doi.org/10.1080/10428194.2016.1219901
https://doi.org/10.1080/10428194.2016.1219901
Autor:
Małgorzata Kuliszkiewicz-Janus, Hanna Janiszewska, Kazimierz Kuliczkowski, Maria Czyżewska, Anna Jachalska, Katarzyna Skonieczka, Olga Haus, Jarosław Czyż, Bożena Jaźwiec, Marek Kielbinski, Anna Jaśkowiec, Aneta Bąk
Publikováno v:
Leukemia research. 70
CHEK2 plays a key role in cellular response to DNA damage, and also in regulation of mitosis and maintenance of chromosomal stability. In patients newly diagnosed with myelodysplastic syndrome (MDS, n = 107) or acute myeloid leukemia (AML, n = 117) c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc2438cef07019102c32dfc2c0410968
https://pubmed.ncbi.nlm.nih.gov/29902706
https://pubmed.ncbi.nlm.nih.gov/29902706
Autor:
Waldemar Sawicki, Aleksandra Gołos, Malwina Mazur, Ewa Bodzenta, Ilona Seferynska, Magdalena Olszewska-Szopa, Marek Hus, Maria Czyżewska, Wojciech Świstek, Maria Bieniaszewska, Joanna Gora Tybor, Marta Sobas, Hubert Wysoglad, Joanna Niesiobedzka-Krezel, Agnieszka Michalska, Elżbieta Patkowska, Olga Grzybowska-Izydorczyk, Krzysztof Jamroziak, Krzysztof Lewandowski, Tomasz Sacha
Publikováno v:
Blood. 134:4180-4180
Background: Ruxolitinib (RUX), an inhibitor of JAK1/JAK2 kinases, is the only drug approved for the treatment of myelofibrosis (MF). The main clinical effects of RUX therapy include decrease of splenomegaly and reduction of burden of constitutional s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::622d4fca18f524195f202e80eeab2afd
https://doi.org/10.1182/blood-2019-125864
https://doi.org/10.1182/blood-2019-125864
Autor:
Aleksandra Kotkowska, Renata Woroniecka, Barbara Mucha, Agnieszka Kopacz, Anna Jachalska, Malgorzata Jarmuz-Szymczak, Olga Haus, Malgorzata Wach, Agnieszka Wierzbowska, Marzena Watek, Maria Czyżewska, Lidia Gil, Anna Ejduk, Anna Jaskowiec, Katarzyna Skonieczka, Jerzy Holowiecki, Justyna Rybka, Ewa Duszenko, Marta Szarawarska, Wanda Knopinska-Posluszny, Sebastian Grosicki, Jadwiga Hołojda, Barbara Pienkowska-Grela, Agnieszka Klonowska, Mariola Iliszko, Anna Przybylowicz-Chalecka, Monika Siemieniuk-Rys, Ewa Wawrzyniak, Tadeusz Robak, Agnieszka Pluta
Publikováno v:
Blood. 124:2347-2347
Objectives:Cytogenetics is one of the most important prognostic factors in acute myeloid leukemia (AML). Two major, partially overlapping cytogenetic subsets of AML associated with an adverse prognosis, are AML with complex karyotype (CK) and AML wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7dfe88edda9f6dea4d5d550da0f6d218
https://doi.org/10.1182/blood.v124.21.2347.2347
https://doi.org/10.1182/blood.v124.21.2347.2347
Autor:
Marek Hus, Aneta Szudy-Szczyrek, Michał Mielnik, Bernatowicz, Pawel L., Jarosław Piszcz, Agnieszka Druzd-Sitek, Maria Czyżewska, Maciej Putowski, Krzysztof Giannopoulos
Publikováno v:
National Information Processing Institute
Medical University of Lublin
Medical University of Lublin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3efeb861d21b1265453df24cb7e707b3
https://journals.viamedica.pl/hematology_in_clinical_practice/article/view/HCP.2021.0002
https://journals.viamedica.pl/hematology_in_clinical_practice/article/view/HCP.2021.0002
